Literature DB >> 15802389

Expression and induction potential of cytochromes P450 in human cryopreserved hepatocytes.

Dirk Roymans1, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens, Willem Meuldermans.   

Abstract

Fresh human hepatocytes are still considered as the "gold standard" to screen in vitro for cytochrome P450 (P450) induction. However, sparse availability of good quality human liver tissue for research purposes and the demand for standardized cell populations, together with the need for proper storage of the cells not immediately required, have resulted in the development of cryopreservation techniques that provide adequate viability and plateability of hepatocytes after thawing. This study aimed at validating cryopreserved human hepatocytes as a model to investigate P450 induction. Cryopreserved cells from four different donors were plated and cultured for 48 h, followed by incubation in the presence of typical P450 inducers. During the experiments, quality of the cultured cells was monitored both physiologically and morphologically. Concomitantly, the activity of CYP1A2, 2B6, 2C9, 2E1, and 3A4 was measured together with their mRNA and protein expression. Determination of CYP1A2, 2B6, 2C9, 2E1, and 3A4 activity in control versus prototypical inducer-treated hepatocytes revealed a maximal significant mean 11.6-, 2.8-, 1.9-, 1.5-, and 9.0-fold induction over their basal expression, respectively. Protein expression analysis of these P450s confirmed these results. Moreover, a mean 44.9-, 3.5-, 3.2-, and 13.8-fold induction of CYP1A2, 2B6, 2C9, and 3A4 mRNA was observed. Our data demonstrate that cryopreserved human hepatocytes are a valuable tool to study the induction of CYP1A2, 2B6, 2C9, 2E1, and 3A4.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802389     DOI: 10.1124/dmd.104.003046

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  Evaluation of human liver slices and reporter gene assays as systems for predicting the cytochrome p450 induction potential of drugs in vivo in humans.

Authors:  Kajsa P Persson; Susanne Ekehed; Charlotta Otter; E S Mareike Lutz; Jane McPheat; Collen M Masimirembwa; Tommy B Andersson
Journal:  Pharm Res       Date:  2006-11-22       Impact factor: 4.200

Review 2.  Hepatocyte cryopreservation: is it time to change the strategy?

Authors:  Xavier Stéphenne; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2010-01-07       Impact factor: 5.742

3.  Assessment of compound hepatotoxicity using human plateable cryopreserved hepatocytes in a 1536-well-plate format.

Authors:  Timothy A Moeller; Sunita J Shukla; Menghang Xia
Journal:  Assay Drug Dev Technol       Date:  2011-11-04       Impact factor: 1.738

Review 4.  Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical.

Authors:  Michael Sinz; Gillian Wallace; Jasminder Sahi
Journal:  AAPS J       Date:  2008-08-07       Impact factor: 4.009

5.  Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach.

Authors:  Rongjun Zuo; Feng Li; Sweta Parikh; Li Cao; Kirsten L Cooper; Yulong Hong; Jin Liu; Ronald A Faris; Daochuan Li; Hongbing Wang
Journal:  Drug Metab Dispos       Date:  2017-01-06       Impact factor: 3.922

6.  Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.

Authors:  Diego Calabrese; Guglielmo Roma; Sebastian Bergling; Walter Carbone; Valentina Mele; Sandro Nuciforo; Isabel Fofana; Benedetta Campana; Dagmara Szkolnicka; David C Hay; Jan Tchorz; Tewis Bouwmeester; Stefan Wieland; Markus H Heim
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

7.  Pharmacokinetic Estimation Models-based Approach to Predict Clinical Implications for CYP Induction by Calcitriol in Human Cryopreserved Hepatocytes and HepaRG Cells.

Authors:  Yoon-Jee Chae; Min-Soo Kim; Suk-Jae Chung; Mi-Kyung Lee; Kyeong-Ryoon Lee; Han-Joo Maeng
Journal:  Pharmaceutics       Date:  2021-01-29       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.